What BIO-TECHNE Corp's executives and directors are doing with their own shares, from SEC Form 3/4/5 filings — separating what the filings state (awards, withholding, disclosed plans) from what only the pattern of dates shows.
| 3 months | 12 months | |
|---|---|---|
| Open-market buys | 0 | 0 |
| Sells | 0 | 2 |
| Total trades | 15 | 58 |
| 3 months | 12 months | |
|---|---|---|
| Acquired | 65,425 | 433,520 |
| Disposed | 18,602 | 308,648 |
| Net activity | +46,823 | +124,872 |
View rich charts and dive into the patterns of specific insiders — who is accumulating, who is winding down, and which sale explanations the filings actually support.
| Insider | Relation | Date | Transaction | Shares | Price | Value | Shares held |
|---|---|---|---|---|---|---|---|
| Hippel James | CFO | Nov 01 | Withheld — tax / exercise cost · F | −5,096 | $72.66 | −$370K | 176,720 |
| Hippel James | CFO | Nov 01 | Exercise / conversion · M | +11,545 | — | — | 181,816 |
| Kelderman Kim | Chief Executive Officer | Nov 01 | Withheld — tax / exercise cost · F | −2,385 | $72.66 | −$173K | 80,509 |
| Baumgartner Robert V | Director | Oct 29 | Grant / award · A | +2,750 | — | — | 59,634 |
| Higgins John L | Director | Oct 29 | Grant / award · A | +2,750 | — | — | 80,004 |
| Seth Alpna | Director | Oct 29 | Grant / award · A | +2,750 | — | — | 18,161 |
| Klimovsky Judith V. | Director | Oct 29 | Grant / award · A | +2,750 | — | — | 6,532 |
| Herr Amy E. | Director | Oct 29 | Grant / award · A | +2,750 | — | — | 5,430 |
| Vessey Rupert | Director | Oct 29 | Grant / award · A | +2,750 | — | — | 13,737 |
| Keegan Joseph D | Director | Oct 29 | Grant / award · A | +2,750 | — | — | 18,161 |
| Bushman Julie L | Director | Oct 29 | Grant / award · A | +2,750 | — | — | 11,525 |
| Higgins John L | Director | Sep 28 | Withheld — tax / exercise cost · F | −5,562 | $72.51 | −$403K | 77,254 |
| Higgins John L | Director | Sep 28 | Exercise / conversion · M | +15,940 | — | — | 82,816 |
| Baumgartner Robert V | Director | Sep 22 | Withheld — tax / exercise cost · F | −5,559 | $72.55 | −$403K | 56,884 |
| Baumgartner Robert V | Director | Sep 22 | Exercise / conversion · M | +15,940 | — | — | 62,443 |
| Bohnen Shane | SVP - General Counsel | Aug 15 | Withheld — tax / exercise cost · F | −1,366 | $72.40 | −$98.9K | 10,407 |
| Bohnen Shane | SVP - General Counsel | Aug 15 | Exercise / conversion · M | +4,420 | — | — | 11,773 |
| Geist William | PRESIDENT, PROTEIN SCIENCES | Aug 15 | Withheld — tax / exercise cost · F | −2,019 | $72.40 | −$146K | 25,031 |
| Geist William | PRESIDENT, PROTEIN SCIENCES | Aug 15 | Exercise / conversion · M | +6,547 | — | — | 27,050 |
| Hippel James | CFO | Aug 15 | Withheld — tax / exercise cost · F | −4,423 | $72.40 | −$320K | 170,271 |
Loading...